Mar 10, 2015
By Michael Kramer
A big step forward in personalized cancer care in British Columbia.
The Cancer Agency there is applauding an experimental treatment that brought a woman with terminal cancer into remission – in only five weeks.
But one of the researchers cautions that it could be years before the treatment is widely used – and it’s still unclear if it will work for all types of cancer.
A trial has been underway since 2012 on Personalized Onco-Genomics- or POG.
The project tests tumours – to decide which drugs might be best to treat them.
Trish Keating had terminal colorectal cancer and faced prolonged chemotherapy. She decided to enrol in the POG program last year.
Testing suggested treating Keating’s tumour with a drug commonly used for high blood pressure – and in only five weeks her cancer was in remission.
Doctor Howard Lim says the use of genomics testing is still experimental – and it could be years before researchers are able to assess its potential impact on cancer treatment.